EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT07138989 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07138989
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-19
- Primary completion
- 2026-08-18
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.